## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r
Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
β Scribed by Reuter, C W M; Morgan, M A; Eckardt, A
- Book ID
- 109999055
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 159 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR
Background. Urokinase-type plasminogen activator is important for matrix degradation and motility of cancer cells. For effective invasion, urokinase has to be associated with its cell surface receptor. 1 Methods. We analyzed 33 head and neck squamous cell carcinomas (hnSCC) and 14 mucosal tissue sam